ISRCTN ISRCTN93284328
DOI https://doi.org/10.1186/ISRCTN93284328
Secondary identifying numbers 4426
Submission date
11/08/2016
Registration date
19/09/2016
Last edited
15/09/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background & Study aims
Kidney dialysis is a medical procedure that removes waste products and excess fluid from the blood in people whose kidneys have stopped working properly, namely patients with chronic kidney disease (CKD) or end stage kidney failure. The procedure is expensive and there is limited availability of these sorts of expensive therapies in the majority of emerging countries and more so in African nations. The aim of this study is to find out whether exercise during haemodialysis (the most common type of kidney dialysis ) has an effect on solute (i.e. waste product) removal from the blood and to identify whether there are any other possible benefits such as preventing deep vein thrombosis, improvement in blood circulation and reduction in swelling and edema (build-up of fluid in the tissues).

Who can participate?
End stage kidney disease patients aged between 30-50 years.

What does the study involve?
This study is called a Quasi-experimental investigation, since patients participating in study know whether they are in the intervention (test) group or the control group. They are randomly allocated to one of the groups. Patients in the intervention group exercise for fifteen minutes every hour using a Airogym exercise cushion. They exercise for a total of sixty minutes during each four-hour hemodialysis session. Patients in the control group do not have to exercise during their 4 hour hemodialysis sessions. Blood is taken from all patients in both groups once a month before and after the session. They are also all encouraged to exercise regularly, eat a healthy diet, get involved in social activities and attend psychological counselling ( if necessary) to maintain their quality of life during the study.

What are the possible benefits and risks of participating?
No benefits are expected for the participants, but this study will improve the future treatment of end-stage kidney disease patients. There is no additional risk involved in this study.

Where is the study run from?
1. Newcastle Private Hospital Renal unit (South Africa)
2. Mediclinic Bloemfontein (South Africa)

Who is funding the study?
Durban University of Technology, Durban (South Africa)

Who is the main contact?
Professor Jamila Khatoon Adam

Contact information

Prof Jamila Khatoon Adam
Scientific

Department of Biomedical & Cllinical Technology
41-43 M L Sultan Road
Durban University of Technology
Durban
4000
South Africa

ORCiD logoORCID ID 0000-0001-6266-699X

Study information

Study designUnblinded randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet.
Scientific titleEffect of exercise on solute removal and edema on end stage renal disease patients
Study acronymAirogym exercise
Study hypothesis1. Patients participating in the intervention group will show marked reduction in edema compared to the control group during a nine- month period of study
2. Patients participating in the intervention group will show a marked increase in solute removal compared to patients in the control group
Ethics approval(s)Institutional Research Ethics Committee, Durban University of Technology, 30/08/2006
ConditionRenal artery obstruction
InterventionBetween September 2006 to December 2006, 34 end stage renal patients for the study were recruited from two MediClinic Hospital Renal Units (namely, Newcastle Private Hospital Renal Unit and Bloemfontein MediClinic Renal Units, South Africa) where they have been on maintenance hemodialysis for at least 3 months.

Participants are randomly allocated to one of two groups.
1. The intervention group: this group exercised on a Airogym exercise cushion for 15 minutes every hour over a 4 hour dialysis session. They exercise for a total of 60 minutes over the 4 hour period.
2. The control group: this group do not have to exercise during their 4 hour dialysis session.

During the first three months of this study patients in the intervention group did not exercise on the exercise cushion (Airogym) to establish a baseline. Thereafter, from the fourth month until the ninth month patients in the intervention group pedalled on the exercise cushion during hemodialysis. All patients exercised at a slow steady rate to target a heart rate of 100 beats per minute and then slowed down gradually. A total of sixty minutes of exercise was performed over the four hours on hemodialysis. Urea, creatinine and potassium were quantitatively measured using standard laboratory techniques from patients (pre and post hemodialysis). Edema of the lower limb was measured in centimeters around the ankles (right and left) before and after dialysis.

Randomisation Method: Random allocation will be utilised to assign the patients to their respective groups, with the patients drawing a letter (A or B) out of an envelope. A total of twenty patients will be recruited from Bloemfontein (ten in group A and ten in group B) and fourteen from Newcastle (seven in group A and seven in group B)

Follow up of patients: On completion of the study, the patients recruited continued on chronic dialysis programme as was recommended by the nephrologist.

The Airogym:
The Airogym was designed specifically to address two common problems associated with long haul flying, i.e., ankle swelling and blood clotting. Patients with end-stage renal disease on haemodialysis are generally more prone to developing deep vein thrombosis, swelling and oedema due to having chronic renal failure. They often feel fatigued and are unable to join an exercise programme at the gymnasium or do any strenuous activities. This inactivity further increases the risk of developing deep vein thrombosis, swelling and oedema due to poor blood circulation. Both can be attributed to stagnation of the circulation. Anybody sitting or standing for long periods of time will notice ankle swelling and pain in the lower legs. Fortunately in the majority of passengers the clots dissolve without causing any apparent symptoms or signs, and leaving no long- term damage. On occasion the blood clot can grow and then a segment can break off and travel to the lungs. There are two problems associated with blood clots, one a clot in the lung, the other an effect which may take many years to manifest itself, namely the development of the post thrombotic limb. The airogym was designed specifically to promote the flow of blood through the deep veins. By pressing down on the footpad, veins in the foot are compressed, squeezing blood into the main veins in the calf. The pressure involved in squeezing the foot causes muscular contractions of the calf muscles promoting the flow of blood through the main veins. Results showed an improvement in peak velocity blood flow up to five times. The device prevented venous stasis and reduced the risk of developing blood clots and also prevented ankle swelling.
Intervention typeDevice
Pharmaceutical study type(s)
Phase
Drug / device / biological / vaccine name(s)
Primary outcome measurePatients experience of the exercise program, measured using questionnaires completed once a month over a nine month period.
Secondary outcome measures1. Urea, creatinine and potassium levels, measured using biochemical analysis of blood samples, taken once a month for nine months from each participant before the dialysis session and afterwards
2. Degree of edema of the lower limb, measured in centimeters around the ankles (right and left) before and after dialysis
3. Statistical Analysis. Paired student’s t-test was used to determine level of significance, using the statistical package SPSS 9.0 for Windows
Overall study start date10/01/2006
Overall study end date30/09/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants34
Participant inclusion criteria1. On a chronic hemodialysis schedule
2. Hemodynamically stable
3. Attending haemodialysis at the Bloemfontein Mediclinic Hospital or Newcastle Private Hospital Renal Unit
4. Receiving haemodialysis twice or three times a week
5. Eighteen years old and above
Participant exclusion criteria1. Patients not on a chronic haemodialysis schedule
2. Patients medically unfit to participate (confirmed by doctor’s incharge of renal unit patients)
3. Patients not willing to comply with protocol
4. Patients that are diabetic
Recruitment start date20/09/2006
Recruitment end date30/12/2006

Locations

Countries of recruitment

  • South Africa

Study participating centres

Newcastle Private Hospital Renal unit
Hospital St, Newcastle
Durban
2940
South Africa
Mediclinic Bloemfontein
Cnr Kellner & Parfitt Street
Westdene
Bloemfontein, Free State
9301
South Africa

Sponsor information

Durban University of Technology
Research organisation

M L Sultan Campus
Department of Biomedical & Clinical Technology
Durban
4000
South Africa

Phone +27 31 373 5291
Email adamjk@dut.ac.za
Website www.dut.ac.za
ROR logo "ROR" https://ror.org/0303y7a51

Funders

Funder type

University/education

Durban University of Technology

No information available

Results and Publications

Intention to publish date01/12/2016
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planThe outcome of the research study will be published in International Medical Journals in 2016.
IPD sharing plan